Literature DB >> 18822250

[Infection and diabetic foot].

E Senneville1.   

Abstract

The large number of factors that influence the outcome of patients with diabetic foot infections calls for a multidisciplinary management of such patients. Infection is always the consequence of a preexisting foot wound whose chronicity is facilitated by the diabetic peripheral neuropathy, whereas peripheral vascular disease is a factor of poor outcome, especially regarding the risk for leg amputation. Primary and secondary prevention of IPD depends both on the efficacy of wound off-loading. Antibiotic treatment should only be considered for clinically infected foot wounds for which diagnostic criteria have recently been proposed by international consensus. The choice of the antibiotic regimen should take into account the risk for selecting bacterial resistance, and as a consequence, agents with a narrow spectrum of activity should be preferred. Respect of the measures for preventing the spread of bacterial resistance in diabetic foot centers is particularly important.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18822250     DOI: 10.1016/S0248-8663(08)73952-3

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  3 in total

1.  Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in diabetic foot ulcers.

Authors:  M Erdogan; S Solmaz; A Canataroglu; M Kulaksızoglu; S Cetinkalp; A G Ozgen; F Saygili; C Yilmaz
Journal:  Endocrine       Date:  2010-04-14       Impact factor: 3.633

2.  [Bacteriological profile of diabetic foot and its impact on the choice of antibiotics].

Authors:  Adil Zemmouri; Mohamed Tarchouli; Abdellatif Benbouha; Tarik Lamkinsi; Mustapha Bensghir; Mostafa Elouennass; Cherqui Haimeur
Journal:  Pan Afr Med J       Date:  2015-02-17

3.  [Approach to podiatric status of the diabetic patient in chronic hemodialysis in a Moroccan hospital].

Authors:  Nawal Benabdellah; Ilham Karimi; Yassamine Bentata; Intissar Haddiya
Journal:  Pan Afr Med J       Date:  2013-09-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.